|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| G01N 33/68 |
| (11) | Number of the document | 2310415 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09734929.4 |
| Date of filing the European patent application | 2009-04-24 | |
| (97) | Date of publication of the European application | 2011-04-20 |
| (45) | Date of publication and mention of the grant of the patent | 2017-10-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/002536 |
| Date | 2009-04-24 |
| (87) | Number | WO 2009/131702 |
| Date | 2009-10-29 |
| (30) | Number | Date | Country code |
| 48152 P | 2008-04-25 | US | |
| 48500 P | 2008-04-28 | US |
| (72) |
TENHOOR, Christopher, US
MURUGANANDAM, Arumugam, IN
LADNER, Robert, Charles, US
WOOD, Clive, US
BITONTI, Alan, J., US
STATTEL, James, US
MCDONNELL, Kevin, US
LIU, Liming, US
DUMONT, Jennifer, US
SATO, Aaron, US
|
| (73) |
Dyax Corp.,
55 Network Drive, Burlington, MA 01803,
US
Biogen Hemophilia Inc., 9 Fourth Avenue, Waltham, MA 02451, US |
| (54) | ANTIBODIES AGAINST FCRN AND USE THEREOF |
| ANTIBODIES AGAINST FCRN AND USE THEREOF |